Clinical Trial Update: Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

View source ↗

Summary

A real-world prospective cohort study in advanced neuroendocrine tumors evaluating survival without persistent limiting toxicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Tumors

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Neuroendocrine (NE) Tumors | Status: NOT_YET_RECRUITING